MHLW Rings Alarm On Drug Ingredients Made From Contaminated Rice
This article was originally published in PharmAsia News
Regarding recent recalls involved drug ingredients that are made of contaminated rice, the Ministry of Health, Labor and Welfare ordered Sept. 18 prefecture governments to investigate and assure that such ingredients are prohibited. Recently, Osaka drug maker Tochimoto Tenkaido recalled two products, Kenpugan and Tochimoto Ruokumigan, for containing rice starch made from the rice contaminated by mold. Tochimoto bought the ingredient from Niigata based Shimada Kakagu Kogyo, and the drug maker has determined that the products have low risks in causing health problems. (Click here for more - Japanese language
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.